See more : Tate & Lyle plc (BD15.L) Income Statement Analysis – Financial Results
Complete financial analysis of Healthpeak Properties, Inc. (PEAK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healthpeak Properties, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Companhia Paranaense de Energia – COPEL (XCOP.MC) Income Statement Analysis – Financial Results
- Cal-Comp Electronics (Thailand) Public Company Limited (CCET.BK) Income Statement Analysis – Financial Results
- Central Telegraph Public Joint Stock Company (CNTLP.ME) Income Statement Analysis – Financial Results
- Outcrop Silver & Gold Corporation (OCG.V) Income Statement Analysis – Financial Results
- Scienjoy Holding Corporation (SJ) Income Statement Analysis – Financial Results
Healthpeak Properties, Inc. (PEAK)
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.18B | 526.64M | 457.70M | 437.51M | 415.28M | 422.55M | 343.58M | 241.03M | 129.44M | 53.33M | 16.80M | 12.95M | 13.85M |
| Cost of Revenue | 902.66M | 171.10M | 137.41M | 128.20M | 124.82M | 122.62M | 97.04M | 66.00M | 31.03M | 10.15M | 4.65M | 4.76M | 4.95M |
| Gross Profit | 1.28B | 355.54M | 320.29M | 309.31M | 290.46M | 299.93M | 246.55M | 175.04M | 98.42M | 43.18M | 12.15M | 8.19M | 8.89M |
| Gross Profit Ratio | 58.61% | 67.51% | 69.98% | 70.70% | 69.94% | 70.98% | 71.76% | 72.62% | 76.03% | 80.96% | 72.32% | 63.25% | 64.23% |
| Research & Development | 0.00 | 0.25 | 0.07 | 0.13 | 0.14 | 0.57 | 0.22 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 95.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Selling & Marketing | 8.00M | 7.90M | 8.00M | 6.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 103.13M | 40.21M | 37.76M | 33.76M | 33.10M | 28.82M | 22.96M | 18.40M | 14.91M | 11.44M | 3.69M | 1.31M | 1.25M |
| Other Expenses | 0.00 | 189.64M | 157.87M | 149.59M | 146.44M | 158.39M | 125.16M | 86.59M | 45.47M | 16.73M | 5.11M | 4.15M | 4.59M |
| Operating Expenses | 103.13M | 229.85M | 195.63M | 183.35M | 179.54M | 187.21M | 148.12M | 104.99M | 60.38M | 28.17M | 8.80M | 5.46M | 5.84M |
| Cost & Expenses | 1.01B | 400.95M | 333.04M | 311.55M | 304.35M | 309.83M | 245.15M | 170.99M | 91.41M | 38.33M | 13.45M | 10.22M | 10.79M |
| Interest Income | 0.00 | 72.23M | 60.14M | 57.18M | 10.90M | 11.56M | 8.49M | 8.86M | 3.88M | 1.07M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 200.33M | 72.23M | 60.14M | 57.18M | 65.02M | 66.18M | 47.01M | 23.86M | 10.64M | 6.91M | 435.25M | 4.54M | 415.46M |
| Depreciation & Amortization | 749.90M | 1.71B | 1.58B | 1.47B | 951.11M | 1.41B | 1.46B | 1.41B | 45.47M | 16.73M | 5.11M | 4.43M | 4.78M |
| EBITDA | 1.19B | 314.54M | 280.96M | 1.13B | 257.34M | 989.69M | 926.97M | 1.29B | 1.13B | 1.16B | 1.71B | 1.51B | 1.25B |
| EBITDA Ratio | 54.54% | 59.73% | 61.39% | 62.69% | 61.97% | 64.19% | 65.13% | 65.03% | 64.59% | 59.69% | 60.44% | 55.27% | 69.32% |
| Operating Income | 1.18B | 124.90M | 123.09M | 124.70M | 110.90M | 112.73M | 98.43M | 70.05M | 38.04M | 15.01M | 1.41M | 1.56M | 1.62M |
| Operating Income Ratio | 53.88% | 23.72% | 26.89% | 28.50% | 26.70% | 26.68% | 28.65% | 29.06% | 29.38% | 28.14% | 8.41% | 12.07% | 11.68% |
| Total Other Income/Expenses | -860.27M | -585.65M | -894.39M | -533.07M | -130.62M | 121.75M | -148.23M | -905.82M | -1.07B | -882.22M | -423.23M | -432.06M | -542.92M |
| Income Before Tax | 314.94M | 110.04M | 86.78M | 68.49M | 77.19M | 58.32M | 39.77M | 31.52M | 12.74M | -4.42M | -2.64M | -2.85M | -3.33M |
| Income Before Tax Ratio | 14.44% | 20.89% | 18.96% | 15.65% | 18.59% | 13.80% | 11.58% | 13.08% | 9.84% | -8.28% | -15.69% | -22.04% | -24.01% |
| Income Tax Expense | -9.62M | 72.23M | 61.38M | 58.29M | 67.70M | 11.78M | 48.82M | 25.52M | 11.69M | 6.62M | 5.59M | 3.34M | 6.11M |
| Net Income | 306.01M | 37.80M | 25.40M | 10.20M | 9.49M | 56.23M | 38.15M | 29.98M | 11.79M | -4.04M | -2.24M | -1.66M | -3.06M |
| Net Income Ratio | 14.03% | 7.18% | 5.55% | 2.33% | 2.28% | 13.31% | 11.10% | 12.44% | 9.11% | -7.57% | -13.32% | -12.79% | -22.10% |
| EPS | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.31 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| EPS Diluted | 0.56 | 0.07 | 0.05 | 0.02 | 0.02 | 0.30 | 0.23 | 0.22 | 0.15 | -0.12 | -0.13 | -0.14 | -0.29 |
| Weighted Avg Shares Out | 547.01M | 538.81M | 538.93M | 204.24M | 185.77M | 470.55M | 163.12M | 138.51M | 79.88M | 36.30M | 14.15M | 11.73M | 11.73M |
| Weighted Avg Shares Out (Dil) | 547.28M | 539.15M | 539.24M | 211.15M | 191.63M | 475.39M | 168.23M | 143.25M | 84.32M | 36.30M | 14.15M | 11.73M | 11.73M |
Healthpeak Properties tops expectations for quarterly FFO
Healthpeak Properties topped market expectations for fourth-quarter funds from operations (FFO) on Thursday, on the back of strong demand for its medical office and life science properties.
Healthpeak Properties Reports Fourth Quarter and Year Ended 2023 Results
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the fourth quarter and full-year ended December 31, 2023. FOURTH QUARTER 2023 FINANCIAL PERFORMANCE AND RECENT...
What's in the Cards for Healthpeak (PEAK) This Earnings Season?
Healthy demand for Healthpeak's (PEAK) lab assets and a rise in senior citizens' healthcare expenditure are expected to have benefited its Q4 earnings despite high interest expenses.
Ahead of Healthpeak (PEAK) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Healthpeak (PEAK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Healthpeak Properties Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report fourth quarter and full year 2023 financial results after the close of trading on the New...
Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.30 per share. The dividend...
3 REITs to Buy if Rates Stay Higher for Longer in 2024
Real estate investment research firm Nareit claims that 2024 is the year REITs are “well-situated for outsized performance.” Nareit based their assessment on the assumption that the Fed is nearing the end of its current interest rate hiking cycle.
Is it Wise to Retain Healthpeak (PEAK) Stock in Your Portfolio?
Solid demand for lab assets and rising healthcare expenditure by senior citizens bode well for Healthpeak (PEAK). However, competition from peers and high interest rates are woes.
Healthpeak Properties Announces Tax Treatment of 2023 Distributions
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced the tax treatment of its 2023 distributions. The following table summarizes, for income tax purposes, the nature of...
Who's Buying BBB+ Rated REITs
Blue-chip REITs are high-quality companies with stable earnings and dividends but they often trade at higher valuations. BBB+ rated REITs offer a balance of safety and potential for growth, with lower entry prices and room for upside. In this article,...
Source: https://incomestatements.info
Category: Stock Reports